Chengxiu Chen - Search Results

Year	Number of Results
1999	3
2001	1
2002	4
2003	2
2005	1
2006	3
2007	2
2009	4
2010	6
2011	7
2012	11
2013	20
2014	11
2015	13
2016	26
2017	34
2018	14
2019	16
2020	19
2021	28
2022	27
2023	40
2024	15

1

Intestinal dysbiosis mediates cognitive impairment via the intestine and brain NLRP3 inflammasome activation in chronic sleep deprivation.

Zhao N, Chen QG, Chen X, Liu XT, Geng F, Zhu MM, Yan FL, Zhang ZJ, Ren QG. Zhao N, et al. Among authors: chen x. Brain Behav Immun. 2023 Feb;108:98-117. doi: 10.1016/j.bbi.2022.11.013. Epub 2022 Nov 24. Brain Behav Immun. 2023. PMID: 36427810

2

The role of circRNAs in cancers.

Zhu LP, He YJ, Hou JC, Chen X, Zhou SY, Yang SJ, Li J, Zhang HD, Hu JH, Zhong SL, Zhao JH, Tang JH. Zhu LP, et al. Among authors: chen x. Biosci Rep. 2017 Oct 24;37(5):BSR20170750. doi: 10.1042/BSR20170750. Print 2017 Oct 31. Biosci Rep. 2017. PMID: 28928231 Free PMC article. Review.

3

Pathogenesis of myopic choroidal neovascularization: A systematic review and meta-analysis.

Zhang XJ, Chen XN, Tang FY, Szeto S, Ling XT, Lin ZX, Tham CC, Pang CP, Chen LJ, Yam JC. Zhang XJ, et al. Among authors: chen xn. Surv Ophthalmol. 2023 Nov-Dec;68(6):1011-1026. doi: 10.1016/j.survophthal.2023.07.006. Epub 2023 Jul 28. Surv Ophthalmol. 2023. PMID: 37517683 Review.

4

Efficacy and safety of FDA-approved IDH inhibitors in the treatment of IDH mutated acute myeloid leukemia: a systematic review and meta-analysis.

Chen X, Xing H, Xie X, Kou L, Li J, Li Y. Chen X, et al. Clin Epigenetics. 2023 Jul 11;15(1):113. doi: 10.1186/s13148-023-01529-2. Clin Epigenetics. 2023. PMID: 37434249 Free PMC article. Review.

5

The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinoma.

Kou L, Xie X, Chen X, Li B, Li J, Li Y. Kou L, et al. Among authors: chen x. Cancer Immunol Immunother. 2023 Dec;72(12):3953-3969. doi: 10.1007/s00262-023-03568-3. Epub 2023 Nov 2. Cancer Immunol Immunother. 2023. PMID: 37917364 Free PMC article. Review.

6

Exosomal microRNA: a novel biomarker for breast cancer.

He Y, Deng F, Yang S, Wang D, Chen X, Zhong S, Zhao J, Tang J. He Y, et al. Among authors: chen x. Biomark Med. 2018 Feb;12(2):177-188. doi: 10.2217/bmm-2017-0305. Epub 2017 Nov 20. Biomark Med. 2018. PMID: 29151358 Review.

7

The anti-cancer properties of heparin and its derivatives: a review and prospect.

Ma SN, Mao ZX, Wu Y, Liang MX, Wang DD, Chen X, Chang PA, Zhang W, Tang JH. Ma SN, et al. Among authors: chen x. Cell Adh Migr. 2020 Dec;14(1):118-128. doi: 10.1080/19336918.2020.1767489. Cell Adh Migr. 2020. PMID: 32538273 Free PMC article. Review.

8

miR-197: A novel biomarker for cancers.

Wang DD, Chen X, Yu DD, Yang SJ, Shen HY, Sha HH, Zhong SL, Zhao JH, Tang JH. Wang DD, et al. Among authors: chen x. Gene. 2016 Oct 15;591(2):313-9. doi: 10.1016/j.gene.2016.06.035. Epub 2016 Jun 17. Gene. 2016. PMID: 27320730 Review.

9

MiRNAs-mediated cisplatin resistance in breast cancer.

Chen X, Lu P, Wu Y, Wang DD, Zhou S, Yang SJ, Shen HY, Zhang XH, Zhao JH, Tang JH. Chen X, et al. Tumour Biol. 2016 Oct;37(10):12905-12913. doi: 10.1007/s13277-016-5216-6. Epub 2016 Jul 22. Tumour Biol. 2016. PMID: 27448297 Review.

10

Prognostic biomarkers associated with immune checkpoint inhibitors in hepatocellular carcinoma.

Chen X, Kou L, Xie X, Su S, Li J, Li Y. Chen X, et al. Immunology. 2024 May;172(1):21-45. doi: 10.1111/imm.13751. Epub 2024 Jan 12. Immunology. 2024. PMID: 38214111 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

278 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

278 results

Results by year